Skip to main content
Neil Shah on Muck Rack

Neil Shah

Verified
New York
As seen in: Techfluential by Deloitte, Yale Daily News, Hello Monday with Jessi Hempel, LinkedIn, Illumination, Medium, MSN, MSN UK, The Startup, Forbes, Nature, The Daily Mirror and
Writing a book about 2010s hip-hop (@doubledaybooks) || Formerly @WSJ music reporter (2015-2025) || drinking margaritas at the mall
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Neil

Contact Neil, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Edison explains: The nuclear resurgence

|
By Neil Shah Verified
| Uncovering Trusts by Edison Group
For most of the past three decades, new nuclear power construction in the West slowed. According to the International Energy Agency (IEA) in the past decade alone 94% of nuclear reactors that started construction were of Chinese or Russian design. Construction in the West was held back by high costs, long timelines and public unease after accidents at Three Mile Island, Chernobyl and Fukushima.
Open in Who Shared Issue with article?

Edison explains: Europe rearms – the small- and mid-caps making up Europe’s defence supply chain

|
By Neil Shah Verified
| Uncovering Trusts by Edison Group
Russia’s full-scale invasion of Ukraine in February 2022 ended Europe’s ‘peace dividend’. In March 2025, the European Commission published its White Paper for European Defence – Readiness 2030, the framework for the ReArm Europe plan and the clearest statement yet of a ‘once-in-a-generation surge’ in defence investment, with the explicit aim of a credible European defence position by 2030.
Open in Who Shared Issue with article?

Immunological mechanisms and therapeutic advances in chronic myeloid leukemia

|
By Nobuko Hijiya, Neil Shah Verified, Kathleen M. Sakamoto, Tiffany K. Ybarra, Ryan S. Sathianathen, Rohaum Hamidi
| Nature Verified
Abstract Chronic myeloid leukemia (CML) is defined by the reciprocal translocation between chromosomes 9 and 22 [t(9;22)], resulting in the constitutively active BCR::ABL1 fusion oncogene in hematopoietic stem cells (HSC). CML is mostly diagnosed in older adults. However, it can also occur in children, adolescents, and young adults.
Open in Who Shared Issue with article?
See all 911 licensed articles (948 Total)